Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Molecular Pharmacology
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Molecular Pharmacology

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Visit molpharm on Facebook
  • Follow molpharm on Twitter
  • Follow molpharm on LinkedIn
Research ArticleArticle

Identification of DNA Repair Pathways That Affect the Survival of Ovarian Cancer Cells Treated with a Poly(ADP-Ribose) Polymerase Inhibitor in a Novel Drug Combination

Amelia M. Huehls, Jill M. Wagner, Catherine J. Huntoon and Larry M. Karnitz
Molecular Pharmacology October 2012, 82 (4) 767-776; DOI: https://doi.org/10.1124/mol.112.080614
Amelia M. Huehls
Division of Oncology Research (A.M.H., J.M.W., C.J.H., L.M.K.), Department of Molecular Pharmacology and Experimental Therapeutics (A.M.H., L.M.K.), and Department of Radiation Oncology (L.M.K.), Mayo Clinic, College of Medicine, Rochester, Minnesota
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jill M. Wagner
Division of Oncology Research (A.M.H., J.M.W., C.J.H., L.M.K.), Department of Molecular Pharmacology and Experimental Therapeutics (A.M.H., L.M.K.), and Department of Radiation Oncology (L.M.K.), Mayo Clinic, College of Medicine, Rochester, Minnesota
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Catherine J. Huntoon
Division of Oncology Research (A.M.H., J.M.W., C.J.H., L.M.K.), Department of Molecular Pharmacology and Experimental Therapeutics (A.M.H., L.M.K.), and Department of Radiation Oncology (L.M.K.), Mayo Clinic, College of Medicine, Rochester, Minnesota
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Larry M. Karnitz
Division of Oncology Research (A.M.H., J.M.W., C.J.H., L.M.K.), Department of Molecular Pharmacology and Experimental Therapeutics (A.M.H., L.M.K.), and Department of Radiation Oncology (L.M.K.), Mayo Clinic, College of Medicine, Rochester, Minnesota
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF + SI
  • PDF
Loading

Article Information

vol. 82 no. 4 767-776
DOI 
https://doi.org/10.1124/mol.112.080614
PubMed 
22833573

Published By 
American Society for Pharmacology and Experimental Therapeutics
Print ISSN 
0026-895X
Online ISSN 
1521-0111
History 
  • Received June 14, 2012
  • Accepted July 24, 2012
  • Published online September 26, 2012.

Article Versions

  • Earlier version (July 25, 2012 - 08:41).
  • You are viewing the most recent version of this article.
Copyright & Usage 
Copyright © 2012 The American Society for Pharmacology and Experimental Therapeutics

Author Information

  1. Amelia M. Huehls,
  2. Jill M. Wagner,
  3. Catherine J. Huntoon, and
  4. Larry M. Karnitz
  1. Division of Oncology Research (A.M.H., J.M.W., C.J.H., L.M.K.), Department of Molecular Pharmacology and Experimental Therapeutics (A.M.H., L.M.K.), and Department of Radiation Oncology (L.M.K.), Mayo Clinic, College of Medicine, Rochester, Minnesota
  1. Address correspondence to:
    Dr. Larry M. Karnitz, Oncology Research, Mayo Clinic, 200 First St. SW, Gonda 19-300, Rochester, MN 55905. E-mail: karnitz.larry{at}mayo.edu
  1. A.M.H., J.M.W., and C.J.H. contributed equally to this study.

View Full Text

Statistics from Altmetric.com

Article usage

Article usage: July 2012 to January 2023

AbstractFullPdf
Jul 20121060130
Aug 20121421233
Sep 201219612157
Oct 20122385376
Nov 20121313350
Dec 2012924150
Jan 20131924449
Feb 2013542133
Mar 2013603643
Apr 2013462724
May 2013372626
Jun 2013232624
Jul 2013422226
Aug 2013431714
Sep 2013811825
Oct 2013251235
Nov 2013162325
Dec 2013144131
Jan 2014302836
Feb 2014272348
Mar 2014111822
Apr 2014154245
May 201475758
Jun 2014106853
Jul 2014161722
Aug 201493532
Sep 2014146559
Oct 2014182919
Nov 2014213630
Dec 2014171419
Jan 2015262859
Feb 201592713
Mar 2015202110
Apr 201513156
May 2015153022
Jun 2015124112
Jul 2015352411
Aug 201524178
Sep 2015331613
Oct 2015201910
Nov 20159118
Dec 201515103
Jan 2016251712
Feb 2016101417
Mar 2016131813
Apr 20165114
May 2016121213
Jun 201612912
Jul 201621234
Aug 201616185
Sep 2016202319
Oct 20165217
Nov 20169122
Dec 20162145
Jan 20170216
Feb 20174265
Mar 20170164
Apr 20170199
May 20173229
Jun 201722210
Jul 201701513
Aug 201712418
Sep 20172215
Oct 20171204
Nov 20171285
Dec 20173307
Jan 20181224
Feb 201822316
Mar 20182305
Apr 20180210
May 201834113
Jun 20180264
Jul 20181183
Aug 20182177
Sep 20180206
Oct 20181154
Nov 20180137
Dec 2018864
Jan 20191133
Feb 2019913
Mar 20191812
Apr 2019633
May 20191667
Jun 20191526
Jul 20191453
Aug 2019934
Sep 20191853
Oct 20191722
Nov 20193223
Dec 20191935
Jan 20201012
Feb 20201622
Mar 20204441
Apr 20201710
May 2020311
Jun 20203000
Jul 20201333
Aug 2020304
Sep 2020904
Oct 20202134
Nov 20201413
Dec 20201912
Jan 202133313
Feb 20212413
Mar 20212035
Apr 20211232
May 20211633
Jun 20211122
Jul 20213426
Aug 20212764
Sep 20211513
Oct 20211532
Nov 20212216
Dec 20212335
Jan 20222223
Feb 20222012
Mar 20221213
Apr 20222911
May 20222110
Jun 20222412
Jul 20223316
Aug 20222434
Sep 20221432
Oct 20221625
Nov 20222128
Dec 20221837
Jan 20232212

PreviousNext
Back to top

In this issue

Molecular Pharmacology: 82 (4)
Molecular Pharmacology
Vol. 82, Issue 4
1 Oct 2012
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by author
  • Editorial Board (PDF)
  • Front Matter (PDF)
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for sharing this Molecular Pharmacology article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
Identification of DNA Repair Pathways That Affect the Survival of Ovarian Cancer Cells Treated with a Poly(ADP-Ribose) Polymerase Inhibitor in a Novel Drug Combination
(Your Name) has forwarded a page to you from Molecular Pharmacology
(Your Name) thought you would be interested in this article in Molecular Pharmacology.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Research ArticleArticle

BRCA1/2 and Rad51 Protect from Floxuridine and ABT-888

Amelia M. Huehls, Jill M. Wagner, Catherine J. Huntoon and Larry M. Karnitz
Molecular Pharmacology October 1, 2012, 82 (4) 767-776; DOI: https://doi.org/10.1124/mol.112.080614

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero

Share
Research ArticleArticle

BRCA1/2 and Rad51 Protect from Floxuridine and ABT-888

Amelia M. Huehls, Jill M. Wagner, Catherine J. Huntoon and Larry M. Karnitz
Molecular Pharmacology October 1, 2012, 82 (4) 767-776; DOI: https://doi.org/10.1124/mol.112.080614
del.icio.us logo Digg logo Reddit logo Twitter logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Introduction
    • Materials and Methods
    • Results
    • Discussion
    • Authorship Contributions
    • Acknowledgments
    • Footnotes
    • References
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF + SI
  • PDF

Related Articles

Cited By...

More in this TOC Section

  • eCB Signaling System in hiPSC-Derived Neuronal Cultures
  • Benzbromarone relaxes airway smooth muscle via BK activation
  • Relapsed-leukemia model with NT5C2/PRPS1 hotspot mutations
Show more Articles

Similar Articles

Advertisement
  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About Molecular Pharmacology
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Drug Metabolism and Disposition
  • Journal of Pharmacology and Experimental Therapeutics
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-0111 (Online)

Copyright © 2023 by the American Society for Pharmacology and Experimental Therapeutics